The intro rate and the standing rate, together
Both single-product injectable pages state the first-month price and the price thereafter in one sentence. That is the disclosure most sellers relegate to a footnote or omit entirely, and it lets a reader see the promotional shape of the offer without doing any work.
This page records the standing rate as the price and the first-month rate as an introductory offer with a stated length, so the two never get confused in a comparison.
The same product at two prices
The microdose tirzepatide product page and the weight-loss overview state different monthly figures for the same pathway. The overview also prices the three-component semaglutide and tirzepatide stacks well above the single-product pages, with different first-month rates again.
Some of that is explicable — a three-component formula is a different product from a single compounded injection — but the microdose discrepancy is not, and nothing on the site reconciles any of it. A reader should note which page a quoted figure came from before treating it as the price.
Two routes, and the oral one costs more
Orally dissolving tablets are priced for both molecules at a stated monthly rate, above the corresponding injection in each case. Publishing an oral route with a real price rather than an enquiry form is uncommon and useful.
The three-component stacks bundle a GLP-1 with two other ingredients under one figure. Those prices are described in this review and are deliberately not recorded as semaglutide or tirzepatide prices, because a blend price is not attributable to a molecule inside the blend.
Brand names appear as memberships
The catalogue lists brand-name products as membership items, so a brand route exists, but no page we read prices one or states what such a membership costs. The membership position is therefore recorded as not published rather than as absent.
No compounding pharmacy is named beyond US-licensed or state-licensed. No list of states served appears anywhere we read, and no individual prescribing clinician or medical director is identified. The site does state on every page that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality.
FORM by GBY's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $159/mothe ongoing monthly rate on the semaglutide product page, which prices the first month lower; the weight-loss overview page states a different pair of figures for its three-component semaglutide stack | September 2026source |
| Tirzepatide (compounded) | $219/mothe ongoing monthly rate on the tirzepatide product page, which prices the first month lower; the weight-loss overview page states a different pair of figures for its three-component tirzepatide stack | September 2026source |
| Tirzepatide (compounded) | $199/moper month on the microdose tirzepatide product page; the weight-loss overview page prices the same microdose pathway at $299 per month, so the site states two figures for one product | September 2026source |
| Semaglutide (compounded-oral) | $215/moper month for the oral route, priced above the weekly injection on the same site | September 2026source |
| Tirzepatide (compounded-oral) | $299/moper month for the oral route, priced above the weekly injection on the same site | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 283 providers reviewed here are paid partners today; the other 279 are not. See how this works.
See FORM by GBY's current price →Good fit if
- Readers who want an oral and an injectable route from one brand, both priced openly.
- Patients who want the introductory rate and the rate that follows it stated in the same sentence.
- Anyone considering a lower-dose pathway, which is priced here as its own product.
- Readers who want the constituents of a stack named rather than hidden behind a product name.
Look elsewhere if
- Anyone who cannot check which page a quoted figure came from, because this site prices the same pathway two ways.
- Readers comparing ongoing costs on headline figures, since every advertised entry price here is a first-month rate.
- Patients who need the compounding pharmacy named or the state footprint published.
- Anyone who wants a priced brand-name route rather than an unpriced membership listing.
How this review was verified
- Read the semaglutide, tirzepatide, microdose tirzepatide and both oral tablet product pages, plus the weight-loss overview, at their source URLs, and logged every figure with the date it was read.
- Recorded the ongoing monthly rate from each single-product page as the price and the first-month rate as an introductory offer of stated length.
- Recorded the disagreement between the microdose product page and the weight-loss overview as a finding rather than choosing between them.
- Did not record the three-component stack figures as a semaglutide or tirzepatide price, because a blend price is not the price of a molecule inside the blend.
- Pulled all 3,677 rows of the FDA warning-letter table and filtered them locally with a known-positive and a nonsense-string control in the same run; no letter found.